RSV vaccines have reportedly fallen since U.S. regulators narrowed the recommended age range and frequency for the shots.

You can find plenty of affordable stocks that offer solid long-term growth prospects. If you're interested in the healthcare ...

New data from GSK's phase III study evaluating a single dose of RSV vaccine Arexvy indicates protection over three RSV ...

Bourla and Shantanu Narayen, Pfizer's lead independent director and Adobe Systems CEO, will hold talks with Starboard chief ...

When Ark Invest (ARK) sold a substantial stake in Palantir (PLTR), it proved too early. PLTR stock continued to rise to an ...

Pfizer to present data across respiratory and other infectious diseases portfolio at IDWeek 2024 congress: New York Thursday, October 10, 2024, 09:00 Hrs [IST] Pfizer Inc. will pr ...

Pfizer Inc. (NYSE:PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet ...

Results from the REVISIT trial show aztreonam-avibactam had similar cure rates as meropenem in patients with serious ...

The prescription-free test you can take at home will help discern which respiratory virus you have, as symptoms often overlap ...

The CDC recommends getting an updated 2024-2025 COVID-19 vaccine to protect against potentially serious illness associated with the latest variants of the virus, noting that protection from vaccines ...

The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.

Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...